Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Aventyn, Inc. · with Dignity Health, Arizona Heart Foundation · NCT07403669
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 300
- US sites recruiting
- 2
- Study start
- October 22, 2025
- Record last updated
- February 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an algorithm obtained from biomarkers and diagnostics utilizing remote sensor driven technology tools, care coordination and patient empowerment.
Being studied: CHAPERONE AI; CKMiq AI; Quality of Life
Conditions: Acute MI; Heart Failure; Diabetes Mellitus; Kidney Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Men and women over 18 years of age are included
- Eligible subjects must have one of the risk factor/ disease component of CKM:
- Diabetes with A1C of 7.5 or higher;
- or Heart disease with stent placement;
- or Coronary Artery Bypass Graft (CABG) in the last 12 months;
- or Chronic Kidney Disease (CKD) stage 2- 4
- and, in those with Heart failure, a recent hospitalization within one week of enrollment is required
Exclusion Criteria
- Those subjects who are not willing to sign an informed consent
Recruiting US locations
Gilbert Cardiology
Gilbert, AZ 85297
Site contact: Sharolyn McClurg Coordinator, MSN, CNP
Arizona Heart Foundation
Phoenix, AZ 85014
Site contact: Eileen Spengler, RCS, FASE
Study contacts (from the official record)
- Navin Govind Steering Committtee, MS · 2317942328 · info@aventyn.com
- Aditya Vijay, MS · 2317942328
Similar studies in Arizona
All diabetes studies in Arizona →- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Chandler, AZ + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Chandler, AZ + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Merck Sharp & Dohme LLC
- Location
- Gilbert, AZ + 27 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
AstraZeneca
- Location
- Phoenix, AZ + 12 other US sites
- Eligibility basics
- Ages 18+